It is a long-acting beta 2 -agonist (laba) indicated for long-term, once-daily, maintenance bronchodilator treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (copd), including chronic bronchitis andemphysema.
Voir plus de détails